- Home
- DVAX vs ALM Comparison
DVAX vs ALM Comparison
Compare DVAX & ALM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVAX
- ALM
- Stock Information
- Founded
- DVAX 1996
- ALM N/A
- Country
- DVAX United States
- ALM Canada
- Employees
- DVAX N/A
- ALM N/A
- Industry
- DVAX Biotechnology: Pharmaceutical Preparations
- ALM Other Metals and Minerals
- Sector
- DVAX Health Care
- ALM Basic Materials
- Exchange
- DVAX Nasdaq
- ALM Nasdaq
- Market Cap
- DVAX 1.2B
- ALM 958.4M
- IPO Year
- DVAX 2004
- ALM N/A
- Fundamental
- Price
- DVAX $10.15
- ALM $7.13
- Analyst Decision
- DVAX Buy
- ALM Strong Buy
- Analyst Count
- DVAX 4
- ALM 2
- Target Price
- DVAX $26.50
- ALM $9.00
- AVG Volume (30 Days)
- DVAX 1.7M
- ALM 1.4M
- Earning Date
- DVAX 11-06-2025
- ALM 11-20-2025
- Dividend Yield
- DVAX N/A
- ALM N/A
- EPS Growth
- DVAX N/A
- ALM N/A
- EPS
- DVAX N/A
- ALM N/A
- Revenue
- DVAX $316,268,000.00
- ALM $20,657,545.00
- Revenue This Year
- DVAX $23.23
- ALM $121.93
- Revenue Next Year
- DVAX $16.57
- ALM $133.39
- P/E Ratio
- DVAX N/A
- ALM N/A
- Revenue Growth
- DVAX 26.66
- ALM 9.87
- 52 Week Low
- DVAX $9.20
- ALM $3.16
- 52 Week High
- DVAX $14.63
- ALM $7.28
- Technical
- Relative Strength Index (RSI)
- DVAX 52.11
- ALM 83.02
- Support Level
- DVAX $9.95
- ALM $5.83
- Resistance Level
- DVAX $10.35
- ALM $6.35
- Average True Range (ATR)
- DVAX 0.29
- ALM 0.37
- MACD
- DVAX 0.08
- ALM 0.12
- Stochastic Oscillator
- DVAX 75.00
- ALM 94.84
About DVAX Dynavax Technologies Corporation
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
About ALM Almonty Industries Inc. Common Shares
Almonty Industries Inc is engaged in the mining, processing, and shipping of tungsten concentrate from its Los Santos tungsten mine located near Salamanca, Spain - the Los Santos Mine, the processing and shipping of tungsten concentrate from its Panasqueira tin and tungsten mine in Covilha, Castelo Branco, Portugal - the Panasqueira Mine, the evaluation of its Valtreixal tin and tungsten mine project located in Western Spain in the province of Zamora - the Valtreixal Mine, as well as the exploration and evaluation of its Sangdong tungsten mine project located in Gangwon Province, Republic of Korea - the Sangdong Mine.